Assembly Biosciences Earnings Estimate
| ASMB Stock | USD 26.85 1.39 4.92% |
Assembly Biosciences Earnings Estimation Breakdown
The calculation of Assembly Biosciences' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Assembly Biosciences is estimated to be -0.9275 with the future projection ranging from a low of -1.0775 to a high of -0.825. Please be aware that this consensus of annual earnings estimates for Assembly Biosciences is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-1.08 Lowest | Expected EPS | -0.82 Highest |
Assembly Biosciences Earnings Projection Consensus
Suppose the current estimates of Assembly Biosciences' value are higher than the current market price of the Assembly Biosciences stock. In this case, investors may conclude that Assembly Biosciences is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Assembly Biosciences' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2025 | Current EPS (TTM) | |
| 4 | 67.48% | -0.72 | -0.9275 | -4.6 |
Assembly Biosciences Earnings per Share Projection vs Actual
Actual Earning per Share of Assembly Biosciences refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Assembly Biosciences predict the company's earnings will be in the future. The higher the earnings per share of Assembly Biosciences, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Assembly Biosciences Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Assembly Biosciences, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Assembly Biosciences should always be considered in relation to other companies to make a more educated investment decision.Assembly Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Assembly Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-11-10 | 2025-09-30 | -1.57 | -0.72 | 0.85 | 54 | ||
2025-08-06 | 2025-06-30 | -1.61 | -1.33 | 0.28 | 17 | ||
2025-05-06 | 2025-03-31 | -1.6 | -1.17 | 0.43 | 26 | ||
2025-03-26 | 2024-12-31 | -1.75 | -1.57 | 0.18 | 10 | ||
2024-11-06 | 2024-09-30 | -2.02 | -1.51 | 0.51 | 25 | ||
2024-08-08 | 2024-06-30 | -2.23 | -2.05 | 0.18 | 8 | ||
2024-05-08 | 2024-03-31 | -3.23 | -1.66 | 1.57 | 48 | ||
2024-01-31 | 2023-12-31 | -2.88 | -2.15 | 0.73 | 25 | ||
2023-11-08 | 2023-09-30 | -0.23 | -0.27 | -0.04 | 17 | ||
2023-08-09 | 2023-06-30 | -0.29 | -0.32 | -0.03 | 10 | ||
2023-05-04 | 2023-03-31 | -0.35 | -0.37 | -0.02 | 5 | ||
2023-03-22 | 2022-12-31 | -0.45 | -0.46 | -0.01 | 2 | ||
2022-11-08 | 2022-09-30 | -0.47 | -0.48 | -0.01 | 2 | ||
2022-08-09 | 2022-06-30 | -0.47 | -0.51 | -0.04 | 8 | ||
2022-05-12 | 2022-03-31 | -0.47 | -0.48 | -0.01 | 2 | ||
2022-03-10 | 2021-12-31 | -0.48 | -0.38 | 0.1 | 20 | ||
2021-11-04 | 2021-09-30 | -0.56 | -0.41 | 0.15 | 26 | ||
2021-08-05 | 2021-06-30 | -0.66 | -0.55 | 0.11 | 16 | ||
2021-05-06 | 2021-03-31 | -0.79 | -0.69 | 0.1 | 12 | ||
2021-02-25 | 2020-12-31 | -0.9 | -0.96 | -0.06 | 6 | ||
2020-11-05 | 2020-09-30 | -0.75 | -0.09 | 0.66 | 88 | ||
2020-08-05 | 2020-06-30 | -0.03 | 0.19 | 0.22 | 733 | ||
2020-05-07 | 2020-03-31 | -0.98 | -0.76 | 0.22 | 22 | ||
2020-03-04 | 2019-12-31 | -1.01 | -0.99 | 0.02 | 1 | ||
2019-11-07 | 2019-09-30 | -0.93 | -0.96 | -0.03 | 3 | ||
2019-08-05 | 2019-06-30 | -1.15 | -0.72 | 0.43 | 37 | ||
2019-05-09 | 2019-03-31 | -1.04 | -1.05 | -0.01 | 0 | ||
2019-02-28 | 2018-12-31 | -0.9 | -1.03 | -0.13 | 14 | ||
2018-11-08 | 2018-09-30 | -1.03 | -0.87 | 0.16 | 15 | ||
2018-08-08 | 2018-06-30 | -0.86 | -1.3 | -0.44 | 51 | ||
2018-05-07 | 2018-03-31 | -0.76 | -0.8 | -0.04 | 5 | ||
2018-03-08 | 2017-12-31 | -0.79 | -0.36 | 0.43 | 54 | ||
2017-11-01 | 2017-09-30 | -0.88 | -0.71 | 0.17 | 19 | ||
2017-08-09 | 2017-06-30 | -0.79 | -0.78 | 0.01 | 1 | ||
2017-05-08 | 2017-03-31 | -0.03 | -0.81 | -0.78 | 2600 | ||
2017-03-02 | 2016-12-31 | -0.67 | -0.67 | 0.0 | 0 | ||
2016-11-09 | 2016-09-30 | -0.67 | -0.67 | 0.0 | 0 | ||
2015-03-12 | 2014-12-31 | -0.57 | -0.38 | 0.19 | 33 | ||
2014-11-17 | 2014-09-30 | -0.48 | -1.33 | -0.85 | 177 | ||
2014-08-14 | 2014-06-30 | -0.65 | -0.52 | 0.13 | 20 | ||
2014-05-14 | 2014-03-31 | -0.7 | -0.9 | -0.2 | 28 | ||
2014-03-17 | 2013-12-31 | -1.4 | -0.29 | 1.11 | 79 | ||
2013-11-12 | 2013-09-30 | -1.3 | -1.25 | 0.05 | 3 | ||
2013-08-09 | 2013-06-30 | -1 | -1.2 | -0.2 | 20 | ||
2013-05-10 | 2013-03-31 | -1.1 | -1.1 | 0.0 | 0 | ||
2013-03-18 | 2012-12-31 | -1.54 | -1.4 | 0.14 | 9 | ||
2012-11-13 | 2012-09-30 | -1.94 | -2.05 | -0.11 | 5 | ||
2012-08-09 | 2012-06-30 | -2.89 | -2.95 | -0.06 | 2 | ||
2012-05-07 | 2012-03-31 | -2.51 | -3.3 | -0.79 | 31 | ||
2012-03-14 | 2011-12-31 | -5.42 | -8.9 | -3.48 | 64 | ||
2011-11-14 | 2011-09-30 | -2.5 | -2.5 | 0.0 | 0 | ||
2011-08-15 | 2011-06-30 | -2.55 | -4.85 | -2.3 | 90 | ||
2011-05-16 | 2011-03-31 | -0.87 | -1.9 | -1.03 | 118 |
About Assembly Biosciences Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Assembly Biosciences earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Assembly Biosciences estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Assembly Biosciences fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -743.3 M | -706.2 M | |
| Retained Earnings Total Equity | -652.1 M | -619.5 M | |
| Earnings Yield | (0.49) | (0.51) | |
| Price Earnings Ratio | (2.12) | (2.23) | |
| Price Earnings To Growth Ratio | 0.04 | 0.04 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Assembly Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Assembly Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Assembly Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Assembly Biosciences Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Assembly Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Assembly Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (4.60) | Revenue Per Share | Quarterly Revenue Growth 0.576 | Return On Assets | Return On Equity |
Assembly Biosciences's market price often diverges from its book value, the accounting figure shown on Assembly's balance sheet. Smart investors calculate Assembly Biosciences' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Assembly Biosciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Assembly Biosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Assembly Biosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.